Sesen Bio up after raising special dividend

Carisma Therapeutics

29/12/2022 21:53

** Shares of cancer therapies developer Sesen Bio  SESN.O 
up ~37% at 68 cents in aftermarket trade
    ** Co nearly triples special cash dividend tied to its
merger with Carisma Therapeutics
    ** Shareholders of SESN will now get $0.34/shr special
dividend, vs $0.12/shr proposed earlier - SESN 
    ** Carisma, based in Philadelphia, develops therapies to
build up immunity 
    ** YTD, stock has plunged more than 38%
 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com;))